The aim of this study was to explore the roles of the long noncoding RNA (lncRNA) urothelial
carcinoma-associated 1 (UCA1) on cisplatin resistance in ovarian cancer and the underlying …

Increasing evidence has demonstrated the involvement of dysregulated long non-coding
RNAs (lncRNAs) in chemoresistance acting as potential oncogenes or tumor suppressors in …

Chemoresistance constitutes the major failing of clinical therapy for bladder cancer.
However, the molecular mechanisms involved in the chemoresistance of bladder cancer are …

Chemotherapy resistance has become the main obstacle for the effective treatment of
human cancers. Long non‐coding RNA urothelial cancer associated 1 (UCA 1) is generally …

Background Chemoresistance contributes to treatment failure of gastric cancer (GC) patients
but the molecular mechanism of chemoresistance in GC is still unclear. Long-chain …

The pivotal role of the long non-coding RNA (lncRNA) urothelial carcinoma associated 1
(UCA1) in anti-cancer drug resistance has been confirmed in many cancers. Overexpression …

Chemotherapy is a reasonable alternative to cystectomy in patients with invasive and
advanced bladder cancer. However, bladder cancer cells often develop drug resistance to …

Background: Drug resistance of cancer cells is one of the major causes of chemotherapy
failure. Recently research demonstrated that long non-coding RNA Urothelial cancer …

Long Non-Coding RNA (lncRNA) Urothelial Carcinoma-Associated 1 (UCA1) Enhances
Tamoxifen Resistance in Breast Cancer Cells via Inhibiting mTOR Signaling Pathway - PMC …

Recent preliminary studies reported the in vitro tumor-promoting effects of long non-coding
RNA urothelial carcinoma associated 1 (UCA1) in colorectal cancer (CRC). However, the in …